HedgeChatter

  • Home /
  • Tag Archives

ISIS

Isis’ CEO Discusses Q4 2013 Results – Earnings Call Transcript

[at Seeking Alpha] – Lynne Parshall Thanks, Wade. Good morning, everyone, and thank you for joining us. 2013 was a year of significant achievement in every aspect of our business. Together with Genzyme, we successfully brought … moreView todays social media effects on ISISView the latest stocks trending across Twitter. Click to view dashboardSee who Isis is hiring next, click […]

February 28, 2014 Bystocknews , Comments Off on Isis’ CEO Discusses Q4 2013 Results – Earnings Call Transcript read more

Isis Reports Financial Results And Highlights For 2013

[PR Newswire] – CARLSBAD, Calif., Feb. 28, 2014 /PRNewswire/ — Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) today announced its 2013 financial results and reviewed the highlights of the year. Isis ended the year in a strong … moreView todays social media effects on ISISView the latest stocks trending across Twitter. Click to view dashboardSee who Isis is hiring next, click here […]

February 28, 2014 Bystocknews , Comments Off on Isis Reports Financial Results And Highlights For 2013 read more

Isis Pharmaceuticals to Present at the Cowen 34th Annual Health Care Conference

[PR Newswire] – CARLSBAD, Calif., Feb. 25, 2014 /PRNewswire/ — Isis Pharmaceuticals, Inc. (ISIS), the leader in antisense therapeutics, today announced that management will present a company overview at the Cowen and Company 34th Annual Health Care Conf moreView todays social media effects on ISISView the latest stocks trending across Twitter. Click to view dashboardSee who Isis is hiring next, […]

February 25, 2014 Bystocknews , Comments Off on Isis Pharmaceuticals to Present at the Cowen 34th Annual Health Care Conference read more

7:01 am ISIS Pharm reports interim results from ISIS-SMN Rx multiple dose study in children with spinal muscular atrophy; average increase of 3.7 points observed in muscle function score in SMA children treated with 9 mg of ISIS-SMN Rx; on

moreView todays social media effects on ISISView the latest stocks trending across Twitter. Click to view dashboardSee who Isis is hiring next, click here to view […]

February 24, 2014 Bystocknews , Comments Off on 7:01 am ISIS Pharm reports interim results from ISIS-SMN Rx multiple dose study in children with spinal muscular atrophy; average increase of 3.7 points observed in muscle function score in SMA children treated with 9 mg of ISIS-SMN Rx; on read more